Investor · New York, NY
Scott Morenstein
Open Scott in the network graph →Filings
52
SEC Form D
Connections
304
co-filers
Capital
$30.4M
across filings
Active
Apr 2014
to Apr 2017
Most-connected co-filers (304)
Kathleen S. Goin · Wayne, PA7 sharedDavid Hirsch · Greenwich, CT7 sharedHeath M. Winter · Takoma Park, MD7 sharedTodd J. Harris · San Diego, CA6 sharedF. F. Drummond · NEW YORK, NY6 sharedScott J. Whisten · NEW YORK, NY6 sharedSiddharth D. Mehta · Trianon, O46 sharedChristoph H. Avenarius-Herborn · Ebene, O46 sharedPaulo S. Rangel · San Diego, CA6 sharedJay R. Cecil · New York, NY6 sharedEvan Lee · Sugar Land, TX6 sharedA. R. Leheny · La Jolla, CA6 sharedPeter M. Young · George Town, Cayman Islands5 sharedJames S. Macleod · NEW YORK, NY5 sharedDan Levitan · Seattle, WA5 sharedDavid Leimbrock · Santa Barbara, CA5 sharedWilliam Mcnabb · NEW YORK, NY5 sharedMichael D. Schneider · SANDPOINT, ID5 sharedRajnish Tahiliani · West Sacramento, CA5 shared3EDGE General Partner, LP · Boston, MA5 sharedAlan B. Rappaport · NEW YORK, NY5 sharedHoward G. Heavin · SANDPOINT, ID5 sharedAlexei Andreev · Menlo Park, CA5 sharedDavid H. Mcclenehan · Sandpoint, ID5 shared
Recent filings (52)
Bay Capital India Fund QPMay 2024 · 10 co-filersBay Capital India Fund QPMay 2023 · 11 co-filersPalvella Therapeutics, Inc.Dec 2022 · 23 co-filers$37.7MBay Capital India Fund QPAug 2022 · 11 co-filersBay Capital India Fund QPMay 2022 · 11 co-filersStorehouse Partners, LLCMar 2022 · 4 co-filers$5.0MAntios Therapeutics Inc.Nov 2021 · 25 co-filers$86.0MBay Capital India Fund QPMay 2021 · 11 co-filersAntios Therapeutics Inc.Apr 2021 · 25 co-filers$100.0MPrimmune Therapeutics, Inc.Nov 2020 · 18 co-filers$24.0MAntios Therapeutics Inc.Aug 2020 · 13 co-filers$5.0MAntios Therapeutics Inc.Aug 2020 · 13 co-filers$5.0MAzurRx BioPharma, Inc.Jul 2020 · 22 co-filers$22.8MPalvella Therapeutics, Inc.Jun 2020 · 27 co-filers$45.0MBay Capital India Fund QPMay 2020 · 11 co-filersCP Oasis LtdMay 2020 · 11 co-filers$800KGuru Technologies, Inc.Apr 2020 · 14 co-filers$30.0MPrimmune Therapeutics, Inc.Mar 2020 · 14 co-filers$3.5MPrimmune Therapeutics, Inc.Mar 2020 · 14 co-filers$4.0MPrimmune Therapeutics, Inc.Mar 2020 · 14 co-filers$4.0MAzurRx BioPharma, Inc.Jan 2020 · 20 co-filers$8.0MMolecular Templates, Inc.Dec 2019 · 28 co-filers$15.0MMolecular Templates, Inc.Nov 2019 · 28 co-filers$15.0MVelicept Therapeutics, Inc.Nov 2019 · 15 co-filers$9.2MVelicept Therapeutics, Inc.Nov 2019 · 15 co-filers$9.2M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Scott in the interactive graph →